about
Modern classification of neoplasms: reconciling differences between morphologic and molecular approachesPathological bases for a robust application of cancer molecular classificationPrediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profilesComplementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsToxicogenomics in drug development.DNA-microarray analysis of brain cancer: molecular classification for therapy.Toxicoproteomics: proteomics applied to toxicology and pathology.The hepatic transcriptome as a window on whole-body physiology and pathophysiology.The role of the toxicologic pathologist in the post-genomic era(#)The role of the toxicologic pathologist in the biopharmaceutical industry.Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.Accelerating drug discovery.Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system.
P2860
Q24813069-D9D91A27-0B39-4C3D-92CF-A6E8B874F0F4Q28082201-3D6E96B4-1687-42E7-9180-1C7B50E42320Q28472125-C6C8C61B-34B2-4149-AA6B-0F7F72E33163Q30939419-BC503D81-97AF-434D-BF15-4EC469D7A2CFQ30939430-D25EE2BD-BE50-4708-B291-FF174205ED52Q35603973-7C9FA3C6-6C3B-4A0D-AA23-54B2AA2549EBQ35614775-825219BB-A300-41C3-B6A0-99D939DA3073Q35892040-E4F9B0BA-1653-42EB-A30B-D5574F31385EQ35973576-A97D92BC-6EEA-461E-B0D6-4AC54CA22C55Q36086424-CD02BA5E-CBC3-40A8-B73B-D5D328E94C76Q36962543-81EE312C-2D9E-4B5A-ACA2-A6E0596F996FQ37924048-434A926B-F1EB-4B49-8B74-A6791FEFE52AQ39617511-64B33EC4-727B-4CCE-8821-CB8465D24334Q40104889-5C373642-CA59-4715-8DC1-F087AD9DEBD6Q44765388-C030456B-0476-4237-8E8A-41C3F245903F
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Toxicogenomics, drug discovery, and the pathologist.
@ast
Toxicogenomics, drug discovery, and the pathologist.
@en
Toxicogenomics, drug discovery, and the pathologist.
@nl
type
label
Toxicogenomics, drug discovery, and the pathologist.
@ast
Toxicogenomics, drug discovery, and the pathologist.
@en
Toxicogenomics, drug discovery, and the pathologist.
@nl
prefLabel
Toxicogenomics, drug discovery, and the pathologist.
@ast
Toxicogenomics, drug discovery, and the pathologist.
@en
Toxicogenomics, drug discovery, and the pathologist.
@nl
P2093
P2860
P1476
Toxicogenomics, drug discovery, and the pathologist.
@en
P2093
Gary A Boorman
K Gottschalk
Kevin T Morgan
Lynn M Crosby
Marilyn Easton
Roger H Brown
Steven P Anderson
Warren M Casey
P2860
P356
10.1080/01926230252824671
P407
P577
2002-01-01T00:00:00Z